GlassScriptPhysician profile
Anna Kalbfell
NPI 1972916914
$3,494.33
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $965 · 2020: $212 · 2022: $474 · 2023: $1,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $289 · Food and Beverage: $54.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $289.37 |
| Food and Beverage | $54.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,229.82 | 2020-2023 | Davinci Xi, Da Vinci Surgical System |
| Coloplast Corp | $1,013.20 | 2019-2020 | |
| Abbvie INC. | $55.34 | 2019 | |
| Organon LLC | $47.73 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $27.78 | 2019-2022 | |
| Lsi Solutions INC | $25.75 | 2022 | |
| Hologic Sales and Service, LLC | $25.49 | 2022 | |
| Coopersurgical, INC. | $14.97 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.38 | 2019 | |
| Novo Nordisk INC | $13.96 | 2022 | |
| Lupin INC. | $13.03 | 2020 | |
| Avion Pharmaceuticals | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Kalbfell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.